Keyphrases
National Cohort Study
100%
Matched Cohort Study
66%
COVID-19
66%
Staphylococcus Aureus
66%
Patients with COVID-19
66%
Hospitalized Patients
66%
Whole Genome Sequencing
66%
Lyme Neuroborreliosis
66%
Confidence Interval
54%
Healthcare-seeking Behavior
37%
Denmark
35%
Population-based Registry
33%
Penicillin Susceptibility
33%
Doxycycline Treatment
33%
Analgesic
33%
Registry-based
33%
Neuroborreliosis
33%
Diagnostic Approach
33%
Diagnostic Evaluation
33%
Hospital Admission
33%
Infectious Diseases
33%
Population Impact
33%
Diabetes
33%
Blood Isolates
33%
Population-based
33%
Sepsis
33%
Fluoroquinolones
33%
BlaZ Gene
33%
Vancomycin-resistant Enterococci
33%
Misinterpretation
33%
Antimicrobial Susceptibility
33%
National Surveillance
33%
Aspergillus Fumigatus
33%
Emergency Department
33%
Blood Culture
33%
Clinical Management
33%
Nested Case-control Study
33%
Surveillance Studies
33%
Novel Variants
33%
Maturity-onset Diabetes of the Young
33%
Candidemia
33%
Azole Resistance
33%
MALDI-TOF Mass Spectrometry
33%
Nosocomial Outbreak
33%
Mycoses
33%
HNF1A
33%
Large Population
33%
Greenland
33%
Meningitis
33%
Neurodevelopmental Disorders
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
77%
Infection
50%
SARS Coronavirus
50%
Antiinfective Agent
48%
Symptom
37%
Attention Deficit Disorder
33%
Neuroborreliosis
33%
Quinolone Derivative
33%
Sepsis
33%
Combination Therapy
33%
Mycosis
33%
Pyrrole
33%
Aspergillus fumigatus
33%
Doxycycline
33%
Respiratory Failure
33%
Bacterial Meningitis
33%
Dexamethasone
33%
Coughing
33%
Meningitis
33%
Candidemia
33%
Remdesivir
33%
Dyspnea
16%
Prematurity
16%
Fatigue
16%
Disease
16%
Acute Disease
16%
Coronavirinae
16%
Penicillin V
12%
Number Needed to Treat
11%
Prevalence
10%
Antibiotic Agent
8%
Enterovirus
8%
Antibiotics
8%
Autism
8%
Emotional Disorder
8%
Behavior Disorder
8%
Developmental Disorder
8%
Medicine and Dentistry
Cohort Analysis
100%
Lyme Neuroborreliosis
66%
COVID-19
33%
Clinical Management
33%
Doxycycline
33%
Urinary System
33%
Neuroborreliosis
33%
Emergency Department
33%
Quinolone Derivative
33%
Anodyne
33%
Antibiogram
33%
Case-Control Study
33%
Disease
33%
Meningitis
33%
Hazard Ratio
25%
Symptom
21%
Attention Deficit Disorder
16%
Bacterial Meningitis
16%
Population
16%
Cerebrospinal Fluid
16%
Antibiotic Therapy
12%
Phenoxymethylpenicillin
12%
Borrelia burgdorferi
11%
Nasal Cannula
11%
Respiratory Failure
11%
Remdesivir
11%
Oxygen Therapy
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Artificial Respiration
11%
Dexamethasone
11%
Continuous Positive Airway Pressure
11%
Combination Therapy
11%
Infection
11%
Time Series Analysis
9%
Medical Specialty
9%
Diagnosis
9%
Diagnostic Procedure
9%
Tramadol
9%
Antibiotics
8%
Childbirth
8%
Prematurity
8%
Drug Therapy
8%
Attributable Risk
7%
Pleocytosis
7%
Opiate
6%
